v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities      
Net loss $ (14,631) $ (9,788)  
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 12,308 11,625  
Amortization of leases 356 324  
Amortization of deferred financing costs 235 241  
Equity-based compensation 4,414 10,751  
Loss on asset disposals 59 47  
Change in fair value of derivative asset 196 350  
Deferred income tax benefit (1,206) (1,464)  
Non-cash interest expense - net 142 173  
Foreign currency loss (gain) - net 806 (2,041)  
Change in fair value of Intermediate Warrants 0 (3,115)  
Loss on extinguishment of debt 0 801  
Change in operating assets and liabilities:      
Accounts receivable - net (5,833) (8,367)  
Inventory - net (10,713) (8,049)  
Prepaid expenses and other current assets (7,558) (1,964)  
Accounts payable 71,479 (6,943)  
Accrued expenses and other current liabilities (2,680) (6,748)  
Deferred revenue (828) (691)  
Long-term lease liabilities (586) (560)  
Other non-current assets and liabilities 47 130  
Net cash provided by (used in) operating activities 46,007 (25,288)  
Cash flows from investing activities      
Purchases of property and equipment (23) (1,836)  
Purchases of personal seat licenses (384) (563)  
Investments in developed technology (2,677) (4,526)  
Purchases of seat images (20) (146)  
Payments toward Acquired Domain Name Obligation 0 (500)  
Net cash used in investing activities (3,104) (7,571)  
Cash flows from financing activities      
Payments for taxes related to net settlement of equity incentive awards (338) (1,411)  
Payments of Acquired Domain Name Obligation (500) 0  
Repurchases of Class A common stock 0 (5,992)  
Payments of liabilities under TRA 0 (4,005)  
Proceeds from 2025 First Lien Loan 0 76,986  
Payments of deferred financing costs and other debt-related expenses 0 (162)  
Net cash used in financing activities (1,821) (11,570)  
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (229) 474  
Net increase (decrease) in cash, cash equivalents, and restricted cash 40,853 (43,955)  
Cash, cash equivalents, and restricted cash - beginning of period 103,306 244,648 $ 244,648
Cash, cash equivalents, and restricted cash - end of period 144,159 200,693 $ 103,306
Supplemental disclosure of cash flow information:      
Cash paid for interest 6,153 7,749  
Cash paid for income tax 55 1,286  
Cash paid for operating lease liabilities 916 897  
Equity-based compensation expense related to capitalized development costs 118 184  
Repurchases of Class A common stock recorded in Accrued expenses and other current liabilities 0 925  
Tax distributions to redeemable noncontrolling interests recorded in Accrued expenses and other current liabilities 0 1,689  
2024 First Lien Loan      
Cash flows from financing activities      
Payments of Loan 0 (76,986)  
2025 First Lien Loan      
Cash flows from financing activities      
Payments of Loan $ (983) $ 0